Pro00113649_R668-EGE-2213: A PHASE 2/3, RANDOMIZED, 3-PART STUDY TO INVESTIGATE THE EFFICACY AND SAFETY OF DUPILUMAB IN ADULT AND ADOLESCENT PATIENTS WITH EOSINOPHILIC GASTRITIS WITH OR WITHOUT EOSINOPHILIC DUODENITIS
Clinical Trial Grant
Administered By
Medicine, Gastroenterology
Awarded By
Regeneron Pharmaceuticals, Inc.
Start Date
February 29, 2024
End Date
January 31, 2026
Administered By
Medicine, Gastroenterology
Awarded By
Regeneron Pharmaceuticals, Inc.
Start Date
February 29, 2024
End Date
January 31, 2026